Log in

HCP Stock Forecast, Price & News

+0.75 (+2.89 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $26.73
50-Day Range
MA: $27.96
52-Week Range
Now: $26.73
Volume2.19 million shs
Average Volume3.01 million shs
Market Capitalization$13.13 billion
P/E Ratio14.69
Dividend Yield4.14%
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More
HCP logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 1.9Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs



Sales & Book Value

Annual Sales$1.85 billion
Cash Flow$2.51 per share
Book Value$13.70 per share


Net Income$1.06 billion


Market Cap$13.13 billion
Next Earnings Date10/28/2020 (Estimated)
+0.75 (+2.89 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HCP News and Ratings via Email

Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

HCP (NYSE:HCP) Frequently Asked Questions

How has HCP's stock been impacted by COVID-19 (Coronavirus)?

HCP's stock was trading at $32.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HCP stock has decreased by 16.7% and is now trading at $26.73.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of HCP?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for HCP

When is HCP's next earnings date?

HCP is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for HCP

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) posted its quarterly earnings results on Wednesday, October, 30th. The real estate investment trust reported ($0.09) EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.43 by $0.52. The real estate investment trust earned $538 million during the quarter, compared to the consensus estimate of $503.65 million. HCP had a net margin of 43.66% and a return on equity of 12.78%. HCP's revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter last year, the business posted $0.44 earnings per share.
View HCP's earnings history

How often does HCP pay dividends? What is the dividend yield for HCP?

HCP announced a quarterly dividend on Wednesday, October 23rd. Investors of record on Monday, November 4th will be paid a dividend of $0.37 per share on Tuesday, November 19th. This represents a $1.48 annualized dividend and a yield of 5.54%. The ex-dividend date is Friday, November 1st.
View HCP's dividend history

What price target have analysts set for HCP?

4 analysts have issued 1-year price objectives for HCP's shares. Their forecasts range from $37.00 to $39.00. On average, they expect HCP's share price to reach $38.00 in the next twelve months. This suggests a possible upside of 42.2% from the stock's current price.
View analysts' price targets for HCP

Who are some of HCP's key competitors?

What other stocks do shareholders of HCP own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HCP investors own include AT&T (T), Welltower (WELL), Omega Healthcare Investors (OHI), Intel (INTC), Realty Income (O), AbbVie (ABBV), Cisco Systems (CSCO), Verizon Communications (VZ), Johnson & Johnson (JNJ) and Walt Disney (DIS).

Who are HCP's key executives?

HCP's management team includes the following people:
  • Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)
  • Mr. Peter A. Scott, Exec. VP & CFO (Age 39)
  • Mr. Thomas M. Klaritch, Exec. VP, COO & Chief Devel. Officer (Age 61)
  • Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42)
  • Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

Who are HCP's major shareholders?

HCP's stock is owned by a variety of retail and institutional investors. Top institutional investors include TCF National Bank (0.00%). Company insiders that own HCP stock include Christine Garvey and Thomas Klaritch.
View institutional ownership trends for HCP

Which institutional investors are buying HCP stock?

HCP stock was bought by a variety of institutional investors in the last quarter, including TCF National Bank.
View insider buying and selling activity for HCP

How do I buy shares of HCP?

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HCP's stock price today?

One share of HCP stock can currently be purchased for approximately $26.73.

How big of a company is HCP?

HCP has a market capitalization of $13.13 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $1.06 billion in net income (profit) each year or $1.82 on an earnings per share basis. HCP employs 201 workers across the globe.

What is HCP's official website?

The official website for HCP is www.hcpi.com.

How can I contact HCP?

HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.